Sales Growth YoY (Last Twelve Months): Rezolute Bio (RZLT)

Graphic logo of Rezolute, Inc. (RZLT)

The success of Rezolute, Inc. (RZLT) is based on ersodetug test outcomes and patent protection. This chart from the GURU.Markets terminal illustrates rolling year-over-year revenue growth rates, where the 0.00 metric serves as the target level. However, a lack of profitability and a cash deficit driven by R&D expenses create tension, while potential secondary offerings in the event of clinical trial failures could dilute shareholder equity.

Sales Growth YoY (Last Twelve Months): Rezolute Corp (RZLT) for 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for Rezolute (RZLT)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:Rezolute, Inc.
Mass-produced product of rezolutebio.com

To objectively assess the operational efficiency of Rezolute, Inc. (RZLT), investors must track the actual dynamics of business scaling. By analyzing the YoY growth of commercial revenue over the LTM, which measures the percentage change in total income over a trailing twelve-month period, one can judge management's ability to monetize clinical successes and secure strategic partnerships amidst regulatory transformations.

Competitor analysis for Rezolute, Inc.

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)